Pliant Therapeutics, Inc.
The Director of Toxicology is a strategic and hands-on scientific leader responsible for shaping and executing nonclinical safety strategies across the discovery and development portfolio. This role provides strong scientific and intellectual leadership across cross-functional teams and represents nonclinical safety in interactions with global regulatory authorities.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2015
Pliant Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of integrin-based therapies. The company leverages its proprietary discovery platform to advance tissue-specific integrin programs targeting a range of diseases, including fibrotic conditions and oncology. Pliant's pipeline includes drug candidates such as PLN-101095 in oncology, with a broader mission to unlock safer and more effective therapies for patients through targeted integrin biology.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Pliant Therapeutics, Inc..
17% above the average for this role
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
Nov 6, 2025
Director, Toxicology
Praxis Precision Medicines, Inc.
Executive Director, Toxicology
Exelixis
Senior Director, Toxicology
Amylyx Pharmaceuticals
Senior Director, Toxicology (CNS Specialist)
Centessa Pharmaceuticals
Senior Vice President, Preclinical Toxicology
Nurix
Principal Scientist, Regulatory Toxicology
CSL